Robin Swartz - 21 Feb 2024 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Signature
/s/ Scott MacDonald, as Attorney-in-Fact for Robin Swartz
Issuer symbol
VYGR
Transactions as of
21 Feb 2024
Net transactions value
-$29,547
Form type
4
Filing time
22 Feb 2024, 16:36:22 UTC
Previous filing
16 Feb 2024
Next filing
03 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYGR Common Stock Sale $29,547 -3,966 -3.2% $7.45 118,361 21 Feb 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 17, 2024. The sales do not represent a discretionary trade by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.36 to $7.52, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.